CART deficiency increases body weight but does not alter bone strength

Journal of Musculoskeletal Neuronal Interactions

Volumn 8, Issue 2, 2008, Pages 146-153

  Bartell, S M ^b   Isales, C M ^a   Baile, C A ^b   Kuhar, M J ^c   Hamrick, Mark W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Adipocyte; Body weight; Bone mass; Cortical bone; Leptin

Indexed keywords

COCAINE AMPHETAMINE RELATED TRANSCRIPT; NEUROPEPTIDE;

ADIPOCYTE; ADULT ANIMAL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE STRENGTH; BONE STRESS; CONTROLLED STUDY; CORTICAL BONE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; MALE; MECHANICAL STRESS; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; OSTEOCLAST; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRABECULAR BONE; WEIGHT GAIN; WILD TYPE;

ABSORPTIOMETRY, PHOTON; ADIPOCYTES; ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; BONE MARROW; CELL COUNT; FEMUR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; TENSILE STRENGTH;

EID: 51749110437     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ducy P, Amling M, Takeda S, Priemel M, Schilling A, Beil F, Shen J, Vinson C, Rueger J, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207.
2. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111:305-17.
3. Amling M, Takeda S, Karsenty G. A neuro (endo)crine regulation of bone remodeling. Bioessays 2000;22:970-5.
4. Karsenty G. Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res 2001;56:401-15.
5. Steppan C Crawford T, Chidsey-Frink K, Ke H, Swick A. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000;92:73-8.
6. Hamrick MW, Pennington C, Newton D, Xie D, Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004;34:376-83.
7. Cornish J, Callon K, Bava U, Lin C, Naot D, Hill B. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002;175:405-15.
8. Reseland J, Gordeladze J. Role of leptin in bone growth: central player or peripheral supporter? FEBS Lett 2002;528:40-2.
9. Iwaniec UT, Boghossian S, Lapke P, Turner R, Kalra S. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides 2007; 28:1012-9.
10. Bray GA, York DA. The MONA LISA hypothesis in the time of leptin. Recent Prog Horm Res 1998;53:95-117.
11. Pierroz D, Muzzin P, Glatt V. β1β2-adrenergic receptor ko mice have decreased total body and cortical bone mass despite increased trabecular bone number. J Bone Miner Res 2004;19(Suppl.1):1121.
12. Elefteriou F, Ahn J, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards W, Bannon T, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005;434:514-20.
13. Hill E, Turner R, Elde R. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 1991;44:747-55.
14. Baldock PA, Allison S, Sainsbury A, Enriquez R, Gardiner EM, Herzog H. Central control of cortical bone homeostasis: Neuropeptide Y exerts a negative effect on cortical bone formation. Frontiers of Skeletal Biology. 11th Workshop on Cell Biology of Bone and Cartilage in Health and Disease. (Davos, Switzerland);2006.
15. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner E, Herzog H. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002;109:915-21.
16. Lunberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, Rost S, Enriquez RF, Sainsbury A, Lamghari M, Simmons P, Eisman JA, Gardiner EM, Herzog H. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 2007;282:19082-91.
17. Baldock PA, Allison SJ, Lunberg P, Lee NJ, Slack K, Lin ED, Enriquez RF, McDonald MM, Zhang L, During MJ, Little DG, Eisman JA, Gardiner EM, Yulyaningsih E, Lin S, Sainsbury A, Herzog H. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem 2007;282:19092-102.
18. Baldock PA, Allison SJ, McDonald MM, Sainsbury A, Enriquez R, Little DG, Eisman JA, Gardiner EM, Herzog H. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 2006;21:1600-7.
19. Koylu EO, Couceyro PR, Lambert PD, Ling NC, DeSouza EB, Kuhar MJ. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol 1997;9:823-33.
20. Hunter RG, Vicentic A, Rogge G, Kuhar MJ. The effects of cocaine on CART expression in the rat nucleus accumbens: a possible role for corticosterone. Eur J Pharmacol 2005;517:45-50.
21. Hunter RG. Philpot K. Vicentic A. Dominguez G. Hubert GW, Kuhar MJ. CART in feeding and obesity. Trends Endocrinol Metab 2004;15:454-9.
22. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998;393:72-6.
23. Mach D, Rogers S, Sabino M, Luger N, Schwei M, Pomonis M, Keyser C, Clohisy D, Adams D, O'Leary P, Mantyh P. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 2000;113:155-66.
24. Duan Y, Beck T, Wang X, Seeman E. Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res 2003;18:1766-74.
25. Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF, Hsiung HM, Köster A. Absence of cocaine-and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 2001;142:4394-400.
26. Ferretti JL. Perspectives of pQCT technology associated to biomechanical studies in skeletal research employing rat models. Bone 1995;17(Suppl.):353S-64S.
27. Gasser JA. Assessing bone quantity by pQCT. Bone 1995;17(Suppl.):145S-54S.
28. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 1996;18:397-403.
29. Montgomery E, Pennington C, Isales CM, Hamrick MW. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat Rec 2005;286A:814-22.
30. Hamrick MW, Samaddar T, Pennington C, McCormick J. Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J Bone Miner Res 2006;21:477-83.
31. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporos Int 2008;19:905-12.
32. Zhang Y, Kilroy G, Henagan T, Pric-Uhing V, Richards WG, Bannon AW, Mynatt RL, Gettys TW. Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J 2005;19:1482-91.
33. Hamrick MW, Della-Fera MA, Choi Y, Pennington C, Hartzell D, Baile CA. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 2005;20:994-1001.
34. Hamrick MW, Della-Fera MA, Hartzell D, Choi Y-H, Baile CA. Intrahypothalamic injections of leptin increase adipocyte apoptosis in peripheral fat pad and in bone marrow. Cell Tissue Res 2007;327:133-41.
35. Nelson-Dooley C, Della-Fera MA, Hamrick MW, Baile CA. Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes. Curr Med Chem 2005;12:2215-25.
36. Thomas T, Gori F, Khosla S, Jensen M, Burguera B, Riggs B. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999;140:1630-8.
37. Justesen J, Stenderup K, Ebbesen E, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001;2:165-71.
38. Verma S, Rajaratnam J, Denton J, Hoyland JA, Byers RJ. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 2002;55:693-8.